Benchmarking of laboratory evolved unspecific peroxygenases for the synthesis of human drug metabolites

Patricia Gomez de Santos; Fadia V. Cervantes; Florian Tieves; Francisco J. Plou; Frank Hollmann; Miguel Alcalde

doi:10.1016/j.tet.2019.02.013

Benchmarking of laboratory evolved unspecific peroxygenases for the synthesis of human drug metabolites

Patricia Gomez de Santos, Fadia V. Cervantes, Florian Tieves, Francisco J. Plou, Frank Hollmann, Miguel Alcalde^*

^*Corresponding author for this work

BT/Biocatalysis

Research output: Contribution to journal › Article › Scientific › peer-review

34 Citations (Scopus)

99 Downloads (Pure)

Abstract

By mimicking the role of human liver P450 monooxygenases, fungal unspecific peroxygenases (UPOs) can perform a range of highly selective oxyfunctionalization reactions on pharmacological compounds, including O-dealkylations and hydroxylations, thereby simulating drug metabolism. Here we have benchmarked human drug metabolite (HDM) synthesis by several evolved UPO mutants, focusing on dextromethorphan, naproxen and tolbutamide. The HDM from dextromethorphan was prepared at the semi-preparative scale as a proof of production. The structural analysis of mutations involved in the synthesis of HDMs highlights the heme access channel as the main feature on which to focus when designing evolved UPOs. These variants are becoming emergent tools for the cost-effective synthesis of HDMs from next-generation drugs.

Original language	English
Pages (from-to)	1827-1831
Number of pages	5
Journal	Tetrahedron
Volume	75
Issue number	13
DOIs	https://doi.org/10.1016/j.tet.2019.02.013
Publication status	Published - 29 Mar 2019

Bibliographical note

Green Open Access added to TU Delft Institutional Repository ‘You share, we take care!’ – Taverne project https://www.openaccess.nl/en/you-share-we-take-care Otherwise as indicated in the copyright section: the publisher is the copyright holder of this work and the author uses the Dutch legislation to make this work public.

Keywords

Dextromethorphan
Heme access channel
Human drug metabolites
Naproxen
Tolbutamide
Unspecific peroxygenase

Access to Document

10.1016/j.tet.2019.02.013

1-s2.0-S0040402019301516-mainFinal published version, 0.99 MB

Cite this

@article{59c2777b75b54c2686cfe37ef32d28a9,

title = "Benchmarking of laboratory evolved unspecific peroxygenases for the synthesis of human drug metabolites",

abstract = "By mimicking the role of human liver P450 monooxygenases, fungal unspecific peroxygenases (UPOs) can perform a range of highly selective oxyfunctionalization reactions on pharmacological compounds, including O-dealkylations and hydroxylations, thereby simulating drug metabolism. Here we have benchmarked human drug metabolite (HDM) synthesis by several evolved UPO mutants, focusing on dextromethorphan, naproxen and tolbutamide. The HDM from dextromethorphan was prepared at the semi-preparative scale as a proof of production. The structural analysis of mutations involved in the synthesis of HDMs highlights the heme access channel as the main feature on which to focus when designing evolved UPOs. These variants are becoming emergent tools for the cost-effective synthesis of HDMs from next-generation drugs.",

keywords = "Dextromethorphan, Heme access channel, Human drug metabolites, Naproxen, Tolbutamide, Unspecific peroxygenase",

author = "{Gomez de Santos}, Patricia and Cervantes, {Fadia V.} and Florian Tieves and Plou, {Francisco J.} and Frank Hollmann and Miguel Alcalde",

note = "Green Open Access added to TU Delft Institutional Repository {\textquoteleft}You share, we take care!{\textquoteright} – Taverne project https://www.openaccess.nl/en/you-share-we-take-care Otherwise as indicated in the copyright section: the publisher is the copyright holder of this work and the author uses the Dutch legislation to make this work public.",

year = "2019",

month = mar,

day = "29",

doi = "10.1016/j.tet.2019.02.013",

language = "English",

volume = "75",

pages = "1827--1831",

journal = "Tetrahedron",

issn = "0040-4020",

publisher = "Elsevier",

number = "13",

}

TY - JOUR

T1 - Benchmarking of laboratory evolved unspecific peroxygenases for the synthesis of human drug metabolites

AU - Gomez de Santos, Patricia

AU - Cervantes, Fadia V.

AU - Tieves, Florian

AU - Plou, Francisco J.

AU - Hollmann, Frank

AU - Alcalde, Miguel

N1 - Green Open Access added to TU Delft Institutional Repository ‘You share, we take care!’ – Taverne project https://www.openaccess.nl/en/you-share-we-take-care Otherwise as indicated in the copyright section: the publisher is the copyright holder of this work and the author uses the Dutch legislation to make this work public.

PY - 2019/3/29

Y1 - 2019/3/29

N2 - By mimicking the role of human liver P450 monooxygenases, fungal unspecific peroxygenases (UPOs) can perform a range of highly selective oxyfunctionalization reactions on pharmacological compounds, including O-dealkylations and hydroxylations, thereby simulating drug metabolism. Here we have benchmarked human drug metabolite (HDM) synthesis by several evolved UPO mutants, focusing on dextromethorphan, naproxen and tolbutamide. The HDM from dextromethorphan was prepared at the semi-preparative scale as a proof of production. The structural analysis of mutations involved in the synthesis of HDMs highlights the heme access channel as the main feature on which to focus when designing evolved UPOs. These variants are becoming emergent tools for the cost-effective synthesis of HDMs from next-generation drugs.

AB - By mimicking the role of human liver P450 monooxygenases, fungal unspecific peroxygenases (UPOs) can perform a range of highly selective oxyfunctionalization reactions on pharmacological compounds, including O-dealkylations and hydroxylations, thereby simulating drug metabolism. Here we have benchmarked human drug metabolite (HDM) synthesis by several evolved UPO mutants, focusing on dextromethorphan, naproxen and tolbutamide. The HDM from dextromethorphan was prepared at the semi-preparative scale as a proof of production. The structural analysis of mutations involved in the synthesis of HDMs highlights the heme access channel as the main feature on which to focus when designing evolved UPOs. These variants are becoming emergent tools for the cost-effective synthesis of HDMs from next-generation drugs.

KW - Dextromethorphan

KW - Heme access channel

KW - Human drug metabolites

KW - Naproxen

KW - Tolbutamide

KW - Unspecific peroxygenase

UR - http://www.scopus.com/inward/record.url?scp=85061657765&partnerID=8YFLogxK

U2 - 10.1016/j.tet.2019.02.013

DO - 10.1016/j.tet.2019.02.013

M3 - Article

SN - 0040-4020

VL - 75

SP - 1827

EP - 1831

JO - Tetrahedron

JF - Tetrahedron

IS - 13

ER -

Benchmarking of laboratory evolved unspecific peroxygenases for the synthesis of human drug metabolites

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this